Prediabetes Screening and Management
Activity Description:
Prediabetes is characterized by glucose levels which are elevated, but do not meet criteria for diabetes. Currently, there are 96 million individuals in the United States with prediabetes, which is 1 in 3 adults. Of these individuals, 80% are unaware of their condition. In New York State, it is estimated that over 5 million people have prediabetes, with 1.5 million reported diagnoses. Projections indicate that prediabetes could affect 1 billion people worldwide by 2045. Prediabetes is associated with obesity, dyslipidemia, and hypertension, and indicates an elevated risk of type 2 diabetes, heart disease, and stroke. By spreading awareness and implementing appropriate screening and interventions, disease progression may be prevented to improve overall health outcomes.
Learning Objectives:
- Define the diagnostic criteria for prediabetes.
- Identify patient risk factors and indications for prediabetes screening.
- Discuss management strategies that incorporate recommended lifestyle modifications, pharmacotherapy, and/or surgical intervention.
Intended Audience: Physicians, physician assistants, nurse practitioners, pharmacists, and other healthcare providers.
Initial Release Date: 11/1/2023
Expiration Date: 10/31/2026
Faculty:
Accreditation Information:
For physicians/providers:
Accreditation: The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians.
Certification: The University at Buffalo Jacobs School of Medicine and Biomedical Sciences designates this Internet Enduring Activity for a maximum of 0.5 AMA PRA Category 1 Credit (TM). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For pharmacists:
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity has been assigned ACPE# 0044-0000-23-045-H01-P and will award 0.5 contact hours (0.05 CEU) of continuing pharmacy education credit. Credit will be uploaded to the CPE Monitor for those who complete all components of this activity.
Activity Components for Continuing Education Credit:
To obtain continuing education credit, complete the required materials. This continuing education activity contains a pre-test, written article, post-test, and program evaluation. Credit will be awarded upon successful completion of the post-test activity, with a score of over 70%.
Disclosures:
The following planners, presenters and others have either indicated financial relationships with ineligible companies or that no financial relationships exist. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. ACCME Standards for Integrity and Independence in Accredited Continuing Education
| The following planners/presenters/others do not have any relevant financial relationships with ineligible companies: | |
| Role in Activity | Name |
| Activity Director, Author | Alexia Sroka, PharmD, BCPS |
| Reviewer, Planner | Edward M. Bednarczyk, PharmD |
| Author | Mia Bersani, PharmD Candidate 2024 |
| Planner | Marsha Nelson |
| Reviewer | Barbara Rogler, PharmD, MS |
| Reviewer, Planner | Deborah Targoff, PharmD |
| Commercial support for this activity (include the name of the ineligible company and nature of the support OR check the box "None") |
| X None |
Software Requirements:
- Chrome
- Firefox
- Safari
- Edge
- Internet Explorer is NOT supported
- Safari 7 and below has known compatibility issues
- Smartphones have limited support. Use a desktop or laptop computer for the best experience.
- Safari
- Chrome
For questions about this activity, please contact: pep@nysdoh.suny.edu